Reference health
Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs
12/12 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 12 checked references that resolve
resolves10.1093/pcmedi/pbaa004
HRCT imaging features in representative imported cases of 2019 novel coronavirus pneumonia
resolves10.1016/S0140-6736(20)30251-8
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
resolves10.1038/s41421-019-0132-8
Bi-directional differentiation of single bronchioalveolar stem cells during lung repair
resolves10.55563/clinexprheumatol/vlncdz
Therapies used in rheumatology with relevance to coronavirus disease 2019
resolves10.55563/clinexprheumatol/xcdary
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
resolves10.1007/s10067-020-05073-9
Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
resolves10.7326/0003-4819-147-8-200710160-00010
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
resolves10.20944/preprints202003.0275.v1
Chloroquine as a Potential Treatment and Prevention Measure for the 2019 Novel Coronavirus: A Review
resolves10.1093/jac/dkaa114
COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression
resolves10.1101/2020.03.24.20042366
Role of Chloroquine and Hydroxychloroquine in the Treatment of COVID-19 Infection- A Systematic Literature Review
resolves10.1016/S1479-666X(06)80021-1
Wegener's granulomatosis: A rare, chronic and multisystem disease
resolves10.1016/S0140-6736(20)30183-5
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
The 3 references without a DOI — listed, not checked
no DOI — not checkedOrganization WH (2020) Coronavirus disease 2019 situation reports.
no DOI — not checkedFerro F, Elefante E, Puxeddu I, Baldini C, Bartoloni E, Baratè C, Galimberti S, Talarico R, Mosca M, Bombardieri S (2020) COVID-19: the new challenge for rheumatologists. First update. Clin Exp Rheumatol 38(3):373–382
no DOI — not checkedBashyam AM, Feldman SR (2020) Should patients stop their biologic treatment during the COVID-19 pandemic. J Dermatol Treat 19:1–2
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1007/s11739-020-02535-5"><img src="https://citestamp.com/citestamped/10.1007/s11739-020-02535-5/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1007/s11739-020-02535-5)